seattletimes.com
Researchers in Seattle and around the world are racing to develop drugs to treat COVID-19 and possibly serve as a bridge until vaccines are widely available. Called monoclonal antibodies, the drugs aim to leverage the body’s immune response to the...
about 4 years ago